Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
01 2Pharmathen SA
02 3APGDI
03 2Alkem Laboratories
04 2Apotex Inc
05 19Astellas Pharma
06 1Aurobindo Pharma Limited
07 2KMS Health Center
08 2Lupin Ltd
09 2QILU PHARMACEUTICAL CO., LTD.
10 1Sawai Pharmaceutical Co
11 2Tecnimede
12 2Unichem Laboratories Limited
13 1Whanin Pharmaceutical
14 2Zydus Pharmaceuticals
01 4Depot tablet
02 5Depottablett
03 2ER Tablet
04 1FOR SUSPENSION, EXTENDED RELEASE;ORAL
05 2PROLONGED-RELEASE TABLET
06 2Prolonged Release Tablet
07 2Prolonged Release Tablets
08 4Ret Tablet
09 2TAB
10 2TABLET (EXTENDED-RELEASE)
11 2TABLET, EXTENDED RELEASE
12 12TABLET, EXTENDED RELEASE;ORAL
13 3Tablet
01 1DISCN
02 4Generic
03 2Originator
04 11RX
05 25Blank
01 1Bemiga SR
02 15Betmiga
03 1Betmiga 25 mg
04 1Betmiga 50 mg
05 12MIRABEGRON
06 4MYRBETRIQ
07 1MYRBETRIQ GRANULES
08 8Blank
01 2Canada
02 2Greece
03 4India
04 9Norway
05 2Portugal
06 2South Africa
07 1South Korea
08 2Sweden
09 4Switzerland
10 15USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2024-02-12
Application Number : 215948
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2024-02-12
Application Number : 215948
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MYRBETRIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2012-06-28
Application Number : 202611
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MYRBETRIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2012-06-28
Application Number : 202611
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MYRBETRIQ GRANULES
Dosage Form : FOR SUSPENSION, EXTENDED RELEASE;ORAL
Dosage Strength : 8MG/ML
Packaging :
Approval Date : 2021-03-25
Application Number : 213801
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2025-01-02
Application Number : 209434
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2025-01-02
Application Number : 209434
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Betmiga
Dosage Form : PROLONGED-RELEASE TABLET
Dosage Strength : 50 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Betmiga
Dosage Form : PROLONGED-RELEASE TABLET
Dosage Strength : 25 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Betmiga
Dosage Form : Depottablett
Dosage Strength : 25 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Betmiga
Dosage Form : Depottablett
Dosage Strength : 25 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Betmiga
Dosage Form : Depottablett
Dosage Strength : 50 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Betmiga
Dosage Form : Depottablett
Dosage Strength : 50 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Betmiga
Dosage Form : Depottablett
Dosage Strength : 50 mg
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 209413
Regulatory Info :
Registration Country : USA
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2022-09-28
Application Number : 209485
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2022-09-28
Application Number : 209485
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2019-12-27
Application Number : 209446
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Portugal
Brand Name :
Dosage Form : Prolonged Release Tablets
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Portugal
Regulatory Info :
Registration Country : Portugal
Brand Name :
Dosage Form : Prolonged Release Tablets
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Portugal
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : ER Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : ER Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2022-09-29
Application Number : 209488
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2022-09-29
Application Number : 209488
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 217989
Regulatory Info :
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : USA
Brand Name : MIRABEGRON
Dosage Form : TABLET, EXTENDED RELEASE
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number : 217989
Regulatory Info :
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
